ATE183241T1 - Impstoff gegen streptococcus suis-infektion - Google Patents
Impstoff gegen streptococcus suis-infektionInfo
- Publication number
- ATE183241T1 ATE183241T1 AT94201295T AT94201295T ATE183241T1 AT E183241 T1 ATE183241 T1 AT E183241T1 AT 94201295 T AT94201295 T AT 94201295T AT 94201295 T AT94201295 T AT 94201295T AT E183241 T1 ATE183241 T1 AT E183241T1
- Authority
- AT
- Austria
- Prior art keywords
- streptococcus suis
- against streptococcus
- vaccine against
- suis infection
- vaccine
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 206010061372 Streptococcal infection Diseases 0.000 title abstract 2
- 241000194021 Streptococcus suis Species 0.000 abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/825—Bacterial vaccine for porcine species, e.g. swine
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93201401 | 1993-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE183241T1 true ATE183241T1 (de) | 1999-08-15 |
Family
ID=8213828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94201295T ATE183241T1 (de) | 1993-05-17 | 1994-05-09 | Impstoff gegen streptococcus suis-infektion |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5612042A (de) |
| EP (1) | EP0626452B1 (de) |
| JP (1) | JP3578799B2 (de) |
| AT (1) | ATE183241T1 (de) |
| CZ (1) | CZ289302B6 (de) |
| DE (1) | DE69419966T2 (de) |
| DK (1) | DK0626452T3 (de) |
| ES (1) | ES2137310T3 (de) |
| GR (1) | GR3031698T3 (de) |
| HU (1) | HU218154B (de) |
| PL (1) | PL177219B1 (de) |
| SK (1) | SK281324B6 (de) |
| TW (1) | TW494103B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI93733C (fi) * | 1993-01-29 | 1995-05-26 | Kaarina Tikkanen | Streptococcus suis-bakteerin adhesiiniproteiini ja menetelmä sen valmistamiseksi |
| US5919466A (en) * | 1993-10-01 | 1999-07-06 | Gerbu Biotechnik Gmbh | Method for improving the yield of immunoantibodies in the vaccination of animals and humans |
| US5863543A (en) * | 1996-06-05 | 1999-01-26 | University Of Saskatchewan | Camp factor of streptococcus uberis |
| US6936259B2 (en) | 1995-06-08 | 2005-08-30 | University Of Saskatchewan | CAMP factor of Streptococcus uberis |
| AU709920B2 (en) * | 1995-06-08 | 1999-09-09 | University Of Saskatchewan | Camp factor of streptococcus uberis |
| ZA97452B (en) * | 1996-01-25 | 1997-08-15 | Trinity College Dublin | Streptococcus equi vaccine. |
| AU769539B2 (en) | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
| FR2791895B1 (fr) * | 1999-03-23 | 2001-06-15 | Pasteur Merieux Serums Vacc | Utilisation de trehalose pour stabiliser un vaccin liquide |
| US7939087B2 (en) * | 2000-10-27 | 2011-05-10 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from Streptococcus groups A & B |
| NO318426B1 (no) | 2001-10-02 | 2005-04-18 | Neurozym Biotech As | Et materiale for a senke konsentrasjonen av patogene tarmpeptider |
| DE10239629A1 (de) * | 2002-08-23 | 2004-04-08 | Idt Impfstoffwerk Dessau-Tornau Gmbh | Nicht-rekombinate Subunit-Vakzine gegen Streptococcus suis-Infektionen des Schweines |
| US20070243199A1 (en) * | 2006-03-30 | 2007-10-18 | Embrex, Inc. | Methods and compositions for vaccination of poultry |
| US7572457B2 (en) * | 2006-03-31 | 2009-08-11 | Wisconsin Alumni Research Foundation | Use of Streptococcus suis 38 kDa polypeptide as an immunogen |
| JP5339243B2 (ja) * | 2008-04-24 | 2013-11-13 | 株式会社微生物化学研究所 | ストレプトコッカス・スイス感染症予防用ワクチン |
| TW201043242A (en) * | 2009-03-26 | 2010-12-16 | Intervet Int Bv | Vaccine for protection against Streptococcus suis bacteria of various serotypes |
| US11155585B2 (en) | 2015-07-09 | 2021-10-26 | Intervacc Ab | Vaccine against S. suis infection |
| US20180271969A1 (en) * | 2015-10-07 | 2018-09-27 | Boehringer Ingelheim Vetmedica, Inc. | Streptococcus suis polysaccharide-protein conjugate composition |
| GB201703529D0 (en) * | 2017-03-06 | 2017-04-19 | Cambridge Entpr Ltd | Vaccine composition |
| CN113957057B (zh) * | 2021-11-16 | 2023-10-20 | 西南大学 | 一种杂交瘤细胞、能中和猪溶素的单克隆抗体及检测试剂盒 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059419A (en) * | 1988-06-09 | 1991-10-22 | Grand Laboratories, Inc. | Streptococcus suis antiserum and its use in treating Streptococcus suis infections |
-
1994
- 1994-05-09 EP EP94201295A patent/EP0626452B1/de not_active Expired - Lifetime
- 1994-05-09 AT AT94201295T patent/ATE183241T1/de not_active IP Right Cessation
- 1994-05-09 DK DK94201295T patent/DK0626452T3/da active
- 1994-05-09 DE DE69419966T patent/DE69419966T2/de not_active Expired - Fee Related
- 1994-05-09 ES ES94201295T patent/ES2137310T3/es not_active Expired - Lifetime
- 1994-05-13 US US08/242,406 patent/US5612042A/en not_active Expired - Fee Related
- 1994-05-13 SK SK563-94A patent/SK281324B6/sk unknown
- 1994-05-13 CZ CZ19941175A patent/CZ289302B6/cs not_active IP Right Cessation
- 1994-05-13 TW TW083104343A patent/TW494103B/zh not_active IP Right Cessation
- 1994-05-16 HU HU9401511A patent/HU218154B/hu not_active IP Right Cessation
- 1994-05-16 PL PL94303482A patent/PL177219B1/pl not_active IP Right Cessation
- 1994-05-17 JP JP10308094A patent/JP3578799B2/ja not_active Expired - Fee Related
-
1999
- 1999-11-03 GR GR990402789T patent/GR3031698T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3578799B2 (ja) | 2004-10-20 |
| HU9401511D0 (en) | 1994-08-29 |
| SK281324B6 (sk) | 2001-02-12 |
| US5612042A (en) | 1997-03-18 |
| ES2137310T3 (es) | 1999-12-16 |
| DE69419966D1 (de) | 1999-09-16 |
| EP0626452A1 (de) | 1994-11-30 |
| EP0626452B1 (de) | 1999-08-11 |
| HUT69796A (en) | 1995-09-28 |
| JPH0710774A (ja) | 1995-01-13 |
| PL177219B1 (pl) | 1999-10-29 |
| PL303482A1 (en) | 1994-12-12 |
| CZ117594A3 (en) | 1995-02-15 |
| GR3031698T3 (en) | 2000-02-29 |
| TW494103B (en) | 2002-07-11 |
| DE69419966T2 (de) | 2000-01-20 |
| DK0626452T3 (da) | 2000-02-14 |
| HU218154B (hu) | 2000-06-28 |
| CZ289302B6 (cs) | 2001-12-12 |
| SK56394A3 (en) | 1995-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE183241T1 (de) | Impstoff gegen streptococcus suis-infektion | |
| EP1712628A3 (de) | Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose | |
| DK0733069T3 (da) | Oprensede Primat CTLA-8-antigener og beslægtede reagenser | |
| WO1999042588A3 (en) | Group b streptococcus antigens | |
| DK0807178T3 (da) | Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose | |
| AU6867801A (en) | Fusion proteins of mycobacterium tuberculosis | |
| SE9500418L (sv) | Nya försvagade Pseudomonas aerugionos stammar | |
| CA2145397A1 (en) | Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines | |
| TW275632B (de) | ||
| EA200100700A1 (ru) | Гены и белки и их применение | |
| DE69524971D1 (de) | Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen | |
| AU2032988A (en) | A genus-specific listeria antigen identified by monoclonal antibodies | |
| EA200100701A1 (ru) | Белки наружной поверхности, их гены и их применение | |
| DE69128095D1 (de) | Azelluläre impfstoffe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |